Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.
de Wild SR, de Munck L, Simons JM, Verloop J, van Dalen T, Elkhuizen PHM, Houben RMA, van Leeuwen AE, Linn SC, Pijnappel RM, Poortmans PMP, Strobbe LJA, Wesseling J, Voogd AC, Boersma LJ. de Wild SR, et al. Among authors: de munck l. Lancet Oncol. 2022 Sep;23(9):1201-1210. doi: 10.1016/S1470-2045(22)00482-X. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952707
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands.
Ruiterkamp J, Ernst MF, de Munck L, van der Heiden-van der Loo M, Bastiaannet E, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC. Ruiterkamp J, et al. Among authors: de munck l. Breast Cancer Res Treat. 2011 Jul;128(2):495-503. doi: 10.1007/s10549-011-1349-x. Epub 2011 Jan 15. Breast Cancer Res Treat. 2011. PMID: 21240629
Early-stage young breast cancer patients: impact of local treatment on survival.
Bantema-Joppe EJ, de Munck L, Visser O, Willemse PH, Langendijk JA, Siesling S, Maduro JH. Bantema-Joppe EJ, et al. Among authors: de munck l. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e553-9. doi: 10.1016/j.ijrobp.2011.02.060. Epub 2011 Sep 9. Int J Radiat Oncol Biol Phys. 2011. PMID: 21601378 Free article.
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
van der Heiden-van der Loo M, de Munck L, Sonke GS, van Dalen T, van Diest PJ, van den Bongard HJ, Peeters PH, Rutgers EJ. van der Heiden-van der Loo M, et al. Among authors: de munck l. Eur J Cancer. 2015 May;51(8):915-21. doi: 10.1016/j.ejca.2015.03.014. Epub 2015 Apr 6. Eur J Cancer. 2015. PMID: 25857549
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC, de Munck L, de Bock GH, Jobsen JJ, van Dalen T, Linn SC, Poortmans P, Strobbe LJA, Siesling S. van Maaren MC, et al. Among authors: de munck l, de bock gh. Lancet Oncol. 2016 Aug;17(8):1158-1170. doi: 10.1016/S1470-2045(16)30067-5. Epub 2016 Jun 22. Lancet Oncol. 2016. PMID: 27344114
Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
van Maaren MC, de Munck L, Jobsen JJ, Poortmans P, de Bock GH, Siesling S, Strobbe LJA. van Maaren MC, et al. Among authors: de munck l, de bock gh. Breast Cancer Res Treat. 2016 Dec;160(3):511-521. doi: 10.1007/s10549-016-4012-8. Epub 2016 Oct 11. Breast Cancer Res Treat. 2016. PMID: 27730424
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients.
Goorts B, van Nijnatten TJ, de Munck L, Moossdorff M, Heuts EM, de Boer M, Lobbes MB, Smidt ML. Goorts B, et al. Among authors: de boer m, de munck l. Breast Cancer Res Treat. 2017 May;163(1):83-91. doi: 10.1007/s10549-017-4155-2. Epub 2017 Feb 15. Breast Cancer Res Treat. 2017. PMID: 28205044 Free PMC article.
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases.
van Nijnatten TJ, Simons JM, Moossdorff M, de Munck L, Lobbes MB, van der Pol CC, Koppert LB, Luiten EJ, Smidt ML. van Nijnatten TJ, et al. Among authors: de munck l. Breast Cancer Res Treat. 2017 May;163(1):159-166. doi: 10.1007/s10549-017-4157-0. Epub 2017 Feb 17. Breast Cancer Res Treat. 2017. PMID: 28213782 Free PMC article.
77 results